<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04750000_2</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q16828</UniProt_ID>
  <Seq_Length>381</Seq_Length>
  <Molecule_Weight>42320</Molecule_Weight>
  <KEGG_ID>hsa:1848</KEGG_ID>
  <Orthology_ID>K04459</Orthology_ID>
  <Function_Summary>Inactivates MAP kinases. Has a specificity for the ERK family.</Function_Summary>
  <Catalytic_Mechanism>Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate.@@A phosphoprotein + H(2)O = a protein + phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF00782:DSPc@@PF00581:Rhodanese</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>12</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Dual specificity protein phosphatase PYST1</Alias>
      <Alias>MKP-3</Alias>
      <Alias>MAP kinase phosphatase 3</Alias>
      <Alias>Mitogen-activated protein kinase phosphatase 3</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: MAP kinase serine/threonine/tyrosine phosphate + H2O = MAP kinase serine/threonine/tyrosine + phosphate.</Detail>
      <Keyword>MAP kinase tyrosine/serine/threonine phosphatase activity</Keyword>
      <Ontology_ID>GO:0017017</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.</Detail>
      <Keyword>Protein tyrosine phosphatase activity</Keyword>
      <Ontology_ID>GO:0004725</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity.</Detail>
      <Keyword>Phosphoprotein phosphatase activity</Keyword>
      <Ontology_ID>GO:0004721</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>114</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>313</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>144</Position>
      <Original>Ser</Original>
      <Variation>Ala</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.</Detail>
      <Keyword>Negative regulation of ERK1 and ERK2 cascade</Keyword>
      <Ontology_ID>GO:0070373</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the TRIF adaptor mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.</Detail>
      <Keyword>TRIF-dependent toll-like receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0035666</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of cell death by apoptosis.</Detail>
      <Keyword>Positive regulation of apoptosis</Keyword>
      <Ontology_ID>GO:0043065</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals generated as a consequence of binding to toll-like receptor 3.</Detail>
      <Keyword>Toll-like receptor 3 signaling pathway</Keyword>
      <Ontology_ID>GO:0034138</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.</Detail>
      <Keyword>Regulation of fibroblast growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0040036</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of the nerve growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Nerve growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0048011</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals generated as a consequence of binding to toll-like receptor 4.</Detail>
      <Keyword>Toll-like receptor 4 signaling pathway</Keyword>
      <Ontology_ID>GO:0034142</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.</Detail>
      <Keyword>Innate immune response</Keyword>
      <Ontology_ID>GO:0045087</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrosative stress stimulus. Nitrosative stress is a state often resulting from exposure to high levels of nitric oxide (NO) or the highly reactive oxidant peroxynitrite, which is produced following interaction of NO with superoxide anions.</Detail>
      <Keyword>Response to nitrosative stress</Keyword>
      <Ontology_ID>GO:0051409</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that mediates the specification of a cell into an endoderm cell.</Detail>
      <Keyword>Regulation of endodermal cell fate specification</Keyword>
      <Ontology_ID>GO:0042663</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the MyD88 adaptor molecule mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.</Detail>
      <Keyword>MyD88-dependent toll-like receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0002755</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals in which a stress-activated MAP kinase cascade relays one or more of the signals; MAP kinase cascades involve at least three protein kinase activities and culminate in the phosphorylation and activation of a MAP kinase.</Detail>
      <Keyword>Stress-activated MAPK cascade</Keyword>
      <Ontology_ID>GO:0051403</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals generated as a consequence of binding to toll-like receptor 1.</Detail>
      <Keyword>Toll-like receptor 1 signaling pathway</Keyword>
      <Ontology_ID>GO:0034130</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.</Detail>
      <Keyword>Dorsal/ventral pattern formation</Keyword>
      <Ontology_ID>GO:0009953</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals initiated by binding of an extracellular ligand to the Toll receptor on the surface of the target cell.</Detail>
      <Keyword>Toll signaling pathway</Keyword>
      <Ontology_ID>GO:0008063</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the rate or extent of heart growth. Heart growth is the increase in size or mass of the heart.</Detail>
      <Keyword>Regulation of heart growth</Keyword>
      <Ontology_ID>GO:0060420</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals generated as a consequence of binding to toll-like receptor 2.</Detail>
      <Keyword>Toll-like receptor 2 signaling pathway</Keyword>
      <Ontology_ID>GO:0034134</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>331</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MIDTLRPVPFASEMAISKTVAWLNEQLELGNERLLLMDCRPQELYESSHIESAINVAIPGIMLRRLQKGNLPVRALFTRGEDRDRFTRRCGTDTVVLYDESSSDWNENTGGESVLGLLLKKLKDEGCRAFYLEGGFSKFQAEFSLHCETNLDGSCSSSSPPLPVLGLGGLRISSDSSSDIESDLDRDPNSATDSDGSPLSNSQPSFPVEILPFLYLGCAKDSTNLDVLEEFGIKYILNVTPNLPNLFENAGEFKYKQIPISDHWSQNLSQFFPEAISFIDEARGKNCGVLVHCLAGISRSVTVTVAYLMQKLNLSMNDAYDIVKMKKSNISPNFNFMGQLLDFERTLGLSSPCDNRVPAQQLYFTTPSNQNVYQVDSLQST</Protein_Seq>
    <DNA_Seq>GAGACGCTCGCTGTTTGTATCCATTGAGGAGCTGCCTCGCGCAGGGGGTGTGCGAGGCTGAGTCCAAGAGATAGCAAATCGAGTCTTAAATAATCCGGGGAGAAAGACGCCCGGGTAGATTTGAGGTGCAGCCTTGGAGGGAGGGATTAGAAGCCGCTAGACTTTTTTTCCTCCCCTCTCAGTAGCACGGAGTCCGAATTAATTGGATTTCATTCACTGGGGAGGAACAAAAACTATCTGGGCAGCTTCATTGAGAGAGATTCATTGACACTAAGAGCCAGCGGCTGCAGCTGGGTGCAGAGAGAACCTCCGGCTTTACTTCTGTCTCGTCTGCCCCAACCGCTAGCCTCGGCTTGGGTAAGGCGAGGCGGAATTAAACCCCGCTCCGAGAGCGGCAGCTTCGCGCGCGGTGCGCTCGGCCTATGCCTGCCCCGAGGGGCGTCTGGTAGGCACCCCGCCCTCTCCCGCAGCTCGACCCCCATGATAGATACGCTCAGACCCGTGCCCTTCGCGTCGGAAATGGCGATCAGCAAGACGGTGGCGTGGCTCAACGAGCAGCTGGAGCTGGGCAACGAGCGGCTGCTGCTGATGGACTGCCGGCCGCAGGAGCTATACGAGTCGTCGCACATCGAGTCGGCCATCAACGTGGCCATCCCGGGCATCATGCTGCGGCGCCTGCAGAAGGGTAACCTGCCGGTGCGCGCGCTCTTCACGCGCGGCGAGGACCGGGACCGCTTCACCCGGCGCTGTGGCACCGACACAGTGGTGCTCTACGACGAGAGCAGCAGCGACTGGAACGAGAATACGGGCGGCGAGTCGGTGCTCGGGCTGCTGCTCAAGAAGCTCAAGGACGAGGGCTGCCGGGCGTTCTACCTGGAAGGTGGCTTCAGTAAGTTCCAAGCCGAGTTCTCCCTGCATTGCGAGACCAATCTAGACGGCTCGTGTAGCAGCAGCTCGCCGCCGTTGCCAGTGCTGGGGCTCGGGGGCCTGCGGATCAGCTCTGACTCTTCCTCGGACATCGAGTCTGACCTTGACCGAGACCCCAATAGTGCAACAGACTCGGATGGTAGTCCGCTGTCCAACAGCCAGCCTTCCTTCCCAGTGGAGATCTTGCCCTTCCTCTACTTGGGCTGTGCCAAAGACTCCACCAACTTGGACGTGTTGGAGGAATTCGGCATCAAGTACATCTTGAACGTCACCCCCAATTTGCCGAATCTCTTTGAGAACGCAGGAGAGTTTAAATACAAGCAAATCCCCATCTCGGATCACTGGAGCCAAAACCTGTCCCAGTTTTTCCCTGAGGCCATTTCTTTCATAGATGAAGCCCGGGGCAAGAACTGTGGTGTCTTGGTACATTGCTTGGCTGGCATTAGCCGCTCAGTCACTGTGACTGTGGCTTACCTTATGCAGAAGCTCAATCTGTCGATGAACGATGCCTATGACATTGTCAAAATGAAAAAATCCAACATATCCCCTAACTTCAACTTCATGGGTCAGCTGCTGGACTTCGAGAGGACGCTGGGACTCAGCAGCCCATGTGACAACAGGGTTCCAGCACAGCAGCTGTATTTTACCACCCCTTCCAACCAGAATGTATACCAGGTGGACTCTCTGCAATCTACGTGAAAGACCCCACACCCCTCCTTGCTGGAATGTGTCTGGCCCTTCAGCAGTTTCTCTTGGCAGCATCAGCTGGGCTGCTTTCTTTGTGTGTGGCCCCAGGTGTCAAAATGACACCAGCTGTCTGTACTAGACAAGGTTACCAAGTGCGGAATTGGTTAATACTAACAGAGAGATTTGCTCCATTCTCTTTGGAATAACAGGACATGCTGTATAGATACAGGCAGTAGGTTTGCTCTGTACCCATGTGTACAGCCTACCCATGCAGGGACTGGGATTCGAGGACTTCCAGGCGCATAGGGTAGAACCAAATGATAGGGTAGGAGCATGTGTTCTTTAGGGCCTTGTAAGGCTGTTTCCTTTTGCATCTGGAACTGACTATATAATTGTCTTCAATGAAGACTAATTCAATTTTGCATATAGAGGAGCCAAAGAGAGATTTCAGCTCTGTATTTGTGGTATCAGTTTGGAAAAAAAAATCTGATACTCCATTTGATTATTGTAAATATTTGATCTTGAATCACTTGACAGTGTTTGTTTGAATTGTGTTTGTTTTTTCCTTTGATGGGCTTAAAAGAAATTATCCAAAGGGAGAAAGAGCAGTATGCCACTTCTTAAAACAGAACAAAACAAAAAAAGAAAATTGTGCTCTTTTCTAATCCAAAGGGTATATTTGCAGCATGCTTGACTTTACCAATTCTGATGACATCTTTACGGACACTATTATCACTAAGACCTTGTTATGGCGAAGTCTTTAGTCTTTTTCATGTATTTTCCTCATGATTTTTTCTCTTTATGTAGTTTGACTATGCCTTACCTTTGTAAATATTTTTGCTTGTGTTGTCGCAAAGGGGATAATCTGGGAAAGACACCAAATCATGGGCTCACTTTAAAAAAAGAAAGAATAAAAAAACCTTCAGCTGTGCTAAACAGTATATTACCTCTGTATAAAATTCTTCAGGGAGTGTCACCTCAAATGCAATACTTTGGGTTGGTTTCTTTCCTTTAAAAAAATTTGTATAAAACTGGAAGTGTGTGTGTGTGAGCATGGGTACCCATTTGATAAGAGAAATGCATTTGATTGTGAAGAAGGGAGAGTTAAATTCTCCATTATGTTCGTGGTGTAAAGTTTAGAGCTGGAATTTATTATAAGAATGTAAAACCTTAAATTATTAATAAATAACTATTTTGGCTATTGAAAAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleoplasm</CellLocal>
      <Ontology_ID>GO:0005654</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>DUSP6</Gene_Name>
    <Gene_Alias>MKP3; PYST1</Gene_Alias>
    <Gene_ID>1848</Gene_ID>
    <Genbank_ACCN>NM_001946</Genbank_ACCN>
    <Protein_ACCN>NP_001937</Protein_ACCN>
    <HGNC_ID>3072</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1848</Gene_URL>
    <UCSC_ID>uc001taz.3</UCSC_ID>
    <EMBL_ID>ENSG00000139318</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Tuberous Sclerosis Complex</Disease_Name>
      <Disease_Detail>Tuberous Sclerosis Complex</Disease_Detail>
      <Disease_DB>TBR022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tuberous_sclerosis_complex?search=DUSP6#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hypogonadotropic Hypogonadism 14 with or Without Anosmia</Disease_Name>
      <Disease_Detail>Hypogonadotropic Hypogonadism</Disease_Detail>
      <Disease_DB>HYP523</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hypogonadotropic_hypogonadism_14_with_or_without_anosmia?search=DUSP6#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hypogonadism</Disease_Name>
      <Disease_Detail>Hypogonadism</Disease_Detail>
      <Disease_DB>HYP080</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hypogonadism?search=DUSP6#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Inclusion Body Myositis</Disease_Name>
      <Disease_Detail>Inclusion Body Myositis</Disease_Detail>
      <Disease_DB>INC002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/inclusion_body_myositis?search=DUSP6#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hypogonadotropic Hypogonadism 19 with or Without Anosmia</Disease_Name>
      <Disease_Detail>Hypogonadotropic Hypogonadism</Disease_Detail>
      <Disease_DB>HYP557</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hypogonadotropic_hypogonadism_19_with_or_without_anosmia?search=DUSP6#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hypogonadotropic Hypogonadism 9 with or Without Anosmia</Disease_Name>
      <Disease_Detail>Hypogonadotropic Hypogonadism</Disease_Detail>
      <Disease_DB>HYP444</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hypogonadotropic_hypogonadism_9_with_or_without_anosmia?search=DUSP6#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF PYST1 (MKP3)</PDB_Title>
      <PDB_ID>1MKP</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1MKP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation.</PubMed_Title>
      <Author>Stewart, A.E., et al.</Author>
      <Journal>Nat.Struct.Biol.(1999)6:174-181</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10048930?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF ERK2 BINDING DOMAIN OF MAPK PHOSPHATASE MKP-3: STRUCTURAL INSIGHTS INTO MKP-3 ACTIVATION BY ERK2</PDB_Title>
      <PDB_ID>1HZM</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HZM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: structural insights into MKP-3 activation by ERK2.</PubMed_Title>
      <Author>Farooq, A., et al.</Author>
      <Journal>Mol.Cell(2001)7:387-399</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11239467?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04010</Pathway_ID>
      <Pathway_Title>MAPK signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04010</Pathway_ID>
      <Pathway_Title>MAPK signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.gh.b.b.d.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1hzm</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Allosteric activation by substrate</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.1.3.16</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/1/3/16.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID> 3.1.3.48</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC 3/1/3/48.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD04750002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04750003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04750004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04750005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04750006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04750007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04750008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04750009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04750010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04750011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04750012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04752001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>